Literature DB >> 17696880

Enhancement by lithium of cAMP-induced CRE/CREB-directed gene transcription conferred by TORC on the CREB basic leucine zipper domain.

Ulrike Böer1, Julia Eglins, Doris Krause, Susanne Schnell, Christof Schöfl, Willhart Knepel.   

Abstract

The molecular mechanism of the action of lithium salts in the treatment of bipolar disorder is not well understood. As their therapeutic action requires chronic treatment, adaptive neuronal processes are suggested to be involved. The molecular basis of this are changes in gene expression regulated by transcription factors such as CREB (cAMP-response-element-binding protein). CREB contains a transactivation domain, in which Ser119 is phosphorylated upon activation, and a bZip (basic leucine zipper domain). The bZip is involved in CREB dimerization and DNA-binding, but also contributes to CREB transactivation by recruiting the coactivator TORC (transducer of regulated CREB). In the present study, the effect of lithium on CRE (cAMP response element)/CREB-directed gene transcription was investigated. Electrically excitable cells were transfected with CRE/CREB-driven luciferase reporter genes. LiCl (6 mM or higher) induced an up to 4.7-fold increase in 8-bromo-cAMP-stimulated CRE/CREB-directed transcription. This increase was not due to enhanced Ser119 phosphorylation or DNA-binding of CREB. Also, the known targets inositol monophosphatase and GSK3beta (glycogen-synthase-kinase 3beta) were not involved as specific GSK3beta inhibitors and inositol replenishment did not mimic and abolish respectively the effect of lithium. However, lithium no longer enhanced CREB activity when the CREB-bZip was deleted or the TORC-binding site inside the CREB-bZip was specifically mutated (CREB-R300A). Otherwise, TORC overexpression conferred lithium responsiveness on CREB-bZip or the CRE-containing truncated rat somatostatin promoter. This indicates that lithium enhances cAMP-induced CRE/CREB-directed transcription, conferred by TORC on the CREB-bZip. We thus support the hypothesis that lithium salts modulate CRE/CREB-dependent gene transcription and suggest the CREB coactivator TORC as a new molecular target of lithium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696880      PMCID: PMC2049075          DOI: 10.1042/BJ20070796

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

Review 1.  Transcriptional regulation by the phosphorylation-dependent factor CREB.

Authors:  B Mayr; M Montminy
Journal:  Nat Rev Mol Cell Biol       Date:  2001-08       Impact factor: 94.444

Review 2.  Molecular neurobiology of addiction.

Authors:  E J Nestler
Journal:  Am J Addict       Date:  2001

Review 3.  Mood stabilizers, glycogen synthase kinase-3beta and cell survival.

Authors:  R S Jope; G N Bijur
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

4.  PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity, but not casein kinase II sites.

Authors:  Darren R Tyson; John T Swarthout; Stephen C Jefcoat; Nicola C Partridge
Journal:  Endocrinology       Date:  2002-02       Impact factor: 4.736

5.  CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium.

Authors:  C A Grimes; R S Jope
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

6.  Reduced CREB phosphorylation after chronic lithium treatment is associated with down-regulation of CaM kinase IV in rat hippocampus.

Authors:  Daniela Tardito; Ettore Tiraboschi; Jiro Kasahara; Giorgio Racagni; Maurizio Popoli
Journal:  Int J Neuropsychopharmacol       Date:  2006-08-21       Impact factor: 5.176

7.  A common mechanism of action for three mood-stabilizing drugs.

Authors:  Robin S B Williams; Lili Cheng; Anne W Mudge; Adrian J Harwood
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

Review 8.  Neurobiology of depression.

Authors:  Eric J Nestler; Michel Barrot; Ralph J DiLeone; Amelia J Eisch; Stephen J Gold; Lisa M Monteggia
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

9.  The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.

Authors:  Haim Einat; Peixiong Yuan; Todd D Gould; Jianling Li; JianHua Du; Lei Zhang; Husseini K Manji; Guang Chen
Journal:  J Neurosci       Date:  2003-08-13       Impact factor: 6.167

10.  Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities.

Authors:  K L Kopnisky; E Chalecka-Franaszek; M Gonzalez-Zulueta; D-M Chuang
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  10 in total

1.  Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.

Authors:  Yuanjie Sun; Nam-Ho Kim; Haijie Yang; Seung-Hyuk Kim; Sung-Oh Huh
Journal:  Mol Cells       Date:  2011-04-14       Impact factor: 5.034

Review 2.  The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.

Authors:  Claudia Pisanu; Urs Heilbronner; Alessio Squassina
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

3.  AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.

Authors:  Nanao Horike; Hideyuki Sakoda; Akifumi Kushiyama; Hiraku Ono; Midori Fujishiro; Hideaki Kamata; Koichi Nishiyama; Yasunobu Uchijima; Yukiko Kurihara; Hiroki Kurihara; Tomoichiro Asano
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

4.  Deregulation of Tpl2 and NF-kappaB signaling and induction of macrophage apoptosis by the anti-depressant drug lithium.

Authors:  Minying Zhang; Wei Jin; Xiaofei Zhou; Jiayi Yu; Andrew J Lee; Shao-Cong Sun
Journal:  Cell Signal       Date:  2008-12-25       Impact factor: 4.315

5.  Lithium promotes DNA stability and survival of ischemic retinal neurocytes by upregulating DNA ligase IV.

Authors:  Ying Yang; Nandan Wu; Sijia Tian; Fan Li; Huan Hu; Pei Chen; Xiaoxiao Cai; Lijun Xu; Jing Zhang; Zhao Chen; Jian Ge; Keming Yu; Jing Zhuang
Journal:  Cell Death Dis       Date:  2016-11-17       Impact factor: 8.469

6.  Effects of GADL1 overexpression on cell migration and the associated morphological changes.

Authors:  Tai-Na Wu; Chih-Ken Chen; I-Chao Liu; Lawrence Shih-Hsin Wu; Andrew Tai-Ann Cheng
Journal:  Sci Rep       Date:  2019-03-28       Impact factor: 4.379

7.  CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma.

Authors:  Zhixian Wang; Xiao Zhang; Xiaoting Tian; Yueyue Yang; Lifang Ma; Jiayi Wang; Yongchun Yu
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

8.  Lithium: a key to the genetics of bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Gustavo Turecki
Journal:  Genome Med       Date:  2009-08-19       Impact factor: 11.117

Review 9.  Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?

Authors:  Lisa Scheuing; Chi-Tso Chiu; Hsiao-Mei Liao; Gabriel R Linares; De-Maw Chuang
Journal:  Int J Biol Sci       Date:  2014-09-10       Impact factor: 6.580

10.  BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology.

Authors:  E N Wilson; S Do Carmo; M F Iulita; H Hall; A Ducatenzeiler; A R Marks; S Allard; D T Jia; J Windheim; A C Cuello
Journal:  Transl Psychiatry       Date:  2017-08-01       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.